Biodesix Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biodesix Inc's ROI in the second quarter of 2026?
Biodesix Inc recorded a cumulative net loss of $-28 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -36.92%.

Within the Healthcare sector 350 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3042 to 3524.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	12.16 %	9.28 %	26.53 %	31.47 %	35.39 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	80	80	70	71	73
Return On Investment (TTM)	-36.92 %	-43.58 %	-49.3 %	-57.68 %	-61.27 %
BDSX's Overall Ranking	# 3524	# 3042	# 2865	# 3301	# 3062
Seq. Investment Change TTM	2.54 %	2.52 %	4.36 %	2.23 %	-0.09 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-28	-32	-35	-40	-41

BDSX Company Profile >> Back to BDSX Roi Comparisons >> See Annual BDSX Return On Investment

Return On Investment BDSX's Ranking
Within:	No.
Industry	# 19
Sector	# 351
Overall	# 3524

Return On Investment Statistics
High	Average	Low
187.28 %	-51.34 %	-155.95 %
(Dec 31 2020)		(Sep 30 2022)

Financial Statements
Biodesix Inc's II. Quarter Investments	$ 80 Millions	BDSX's Balance sheet
Biodesix Inc's II. Quarter Income	$ -7 Millions	Quarterly BDSX's Income Statement
BDSX's Income by Division		See BDSX's Income by Division

BDSX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	46	58	41	70	47
Y / Y Investment Growth	-20.82 %	43.39 %	-42.17 %	48.65 %	-47 %
Net Income in Millions	-35	-43	-52	-65	-43
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-76.66 %	-73.89 %	-128.7 %	-93.41 %	-91.56 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDSX's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BDSX's Competitors
Subscribers only: Roi for Biodesix Inc's Suppliers
Subscribers only: Return On Investment for BDSX's Customers

Other Ratios
BDSX's Roa	BDSX's Inventory Turnover Ratio	BDSX's Growth Rates	BDSX's Dividend Statistics
	BDSX's Profitability Ratios	BDSX's Asset Turnover Ratio	BDSX's Dividend Growth
BDSX's Roe	BDSX's Valuation Ratios	BDSX's Financial Strength Ratios	BDSX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-10T09:11:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.